Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas

Introduction: Hematopoietic neoplasms are often driven by gain-of-function mutations of the JAK-STAT pathway together with mutations in chromatin remodeling and DNA damage control pathways. The interconnection between the JAK-STAT pathway, epigenetic regulation or DNA damage control is still poorly...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Expert Opin Ther Targets
Autors principals: Orlova, Anna, Wingelhofer, Bettina, Neubauer, Heidi A., Maurer, Barbara, Berger-Becvar, Angelika, Keserű, György Miklós, Gunning, Patrick T., Valent, Peter, Moriggl, Richard
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2017
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5743003/
https://ncbi.nlm.nih.gov/pubmed/29148847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728222.2018.1406924
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars